File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Sudden cardiac death: Prevention and treatment

TitleSudden cardiac death: Prevention and treatment
Authors
KeywordsAnti-arrhythmia agents
Cardiopulmonary resuscitation
Defibrillators, imptantable
Heart arrest
Treatment outcome
Issue Date2003
PublisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.html
Citation
Hong Kong Medical Journal, 2003, v. 9 n. 5, p. 357-362 How to Cite?
AbstractSudden cardiac death remains a major health issue in western countries as well as in Hong Kong. Despite increasing knowledge of the mechanisms and risk factors of sudden cardiac death, methods for identifying high-risk candidates and predicting the efficacy of measures to prevent sudden cardiac death are still inadequate. A significant proportion of patients have known heart disease but are generally considered to be at low risk for this event. More efforts are needed to improve the success rate of out-of-hospital resuscitation through better warning systems, the use of amiodarone for refractory arrhythmias, and the widespread availability of automated defibrillation devices to allow early defibrillation. It is likely that these measures could increase the number of survivors following cardiac arrest. In survivors of sudden cardiac death episodes, treatment of the underlying cardiac disease, especially early revascularisation for myocardial ischaemia, is required. In the majority of patients, implantation of an implantable cardioverter defibrillator, with or without the use of an anti-arrhythmic drug such as amiodarone, would then be used to maintain survival. Furthermore, for individuals at significant risk of sudden cardiac death, primary prevention of sudden cardiac death through the placement of an implantable cardioverter defibrillator is increasingly being used.
Persistent Identifierhttp://hdl.handle.net/10722/45151
ISSN
2015 Impact Factor: 0.887
2015 SCImago Journal Rankings: 0.279
References

 

DC FieldValueLanguage
dc.contributor.authorKwok, KMen_HK
dc.contributor.authorLee, KLFen_HK
dc.contributor.authorLau, CPen_HK
dc.contributor.authorTse, HFen_HK
dc.date.accessioned2007-10-30T06:18:26Z-
dc.date.available2007-10-30T06:18:26Z-
dc.date.issued2003en_HK
dc.identifier.citationHong Kong Medical Journal, 2003, v. 9 n. 5, p. 357-362en_HK
dc.identifier.issn1024-2708en_HK
dc.identifier.urihttp://hdl.handle.net/10722/45151-
dc.description.abstractSudden cardiac death remains a major health issue in western countries as well as in Hong Kong. Despite increasing knowledge of the mechanisms and risk factors of sudden cardiac death, methods for identifying high-risk candidates and predicting the efficacy of measures to prevent sudden cardiac death are still inadequate. A significant proportion of patients have known heart disease but are generally considered to be at low risk for this event. More efforts are needed to improve the success rate of out-of-hospital resuscitation through better warning systems, the use of amiodarone for refractory arrhythmias, and the widespread availability of automated defibrillation devices to allow early defibrillation. It is likely that these measures could increase the number of survivors following cardiac arrest. In survivors of sudden cardiac death episodes, treatment of the underlying cardiac disease, especially early revascularisation for myocardial ischaemia, is required. In the majority of patients, implantation of an implantable cardioverter defibrillator, with or without the use of an anti-arrhythmic drug such as amiodarone, would then be used to maintain survival. Furthermore, for individuals at significant risk of sudden cardiac death, primary prevention of sudden cardiac death through the placement of an implantable cardioverter defibrillator is increasingly being used.en_HK
dc.format.extent730709 bytes-
dc.format.extent19303 bytes-
dc.format.extent6332 bytes-
dc.format.mimetypeapplication/pdf-
dc.format.mimetypetext/plain-
dc.format.mimetypetext/plain-
dc.languageengen_HK
dc.publisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.htmlen_HK
dc.relation.ispartofHong Kong Medical Journalen_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.subjectAnti-arrhythmia agentsen_HK
dc.subjectCardiopulmonary resuscitationen_HK
dc.subjectDefibrillators, imptantableen_HK
dc.subjectHeart arresten_HK
dc.subjectTreatment outcomeen_HK
dc.subject.meshDeath, Sudden, Cardiac - epidemiology - etiology - prevention & controlen_HK
dc.subject.meshAdrenergic beta-Antagonists - therapeutic useen_HK
dc.subject.meshArrhythmia - complications - therapyen_HK
dc.subject.meshDefibrillators, Implantable - contraindications - standardsen_HK
dc.subject.meshElectric Countershocken_HK
dc.titleSudden cardiac death: Prevention and treatmenten_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1024-2708&volume=9&issue=5&spage=357&epage=62&date=2003&atitle=Sudden+cardiac+death:+prevention+and+treatmenten_HK
dc.identifier.emailTse, HF:hftse@hkucc.hku.hken_HK
dc.identifier.authorityTse, HF=rp00428en_HK
dc.description.naturepublished_or_final_versionen_HK
dc.identifier.pmid14530531-
dc.identifier.scopuseid_2-s2.0-0141962381en_HK
dc.identifier.hkuros88018-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0141962381&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume9en_HK
dc.identifier.issue5en_HK
dc.identifier.spage357en_HK
dc.identifier.epage362en_HK
dc.publisher.placeHong Kongen_HK
dc.identifier.scopusauthoridKwok, KM=7102194184en_HK
dc.identifier.scopusauthoridLee, KLF=7501505962en_HK
dc.identifier.scopusauthoridLau, CP=7401968501en_HK
dc.identifier.scopusauthoridTse, HF=7006070805en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats